Hormonal management of early endometrial cancer

Abstract

Approximately 3–5% of patients diagnosed with endometrial cancer in the United States are under the age of 40. For these patients, fertility preservation is often of paramount importance. Patients with endometrial cancer and other medical co-morbidities are not ideal surgical candidates and may also be candidates for medical therapy. After careful selection and counseling, certain patients with Grade 1 endometrial cancer may be offered treatment with progesterone therapy.